-+ 0.00%
-+ 0.00%
-+ 0.00%

Fluicell's Cancer Drug Delivery Catheter Meets Ambusol's Functional Requirements

PUBT·11/09/2026 07:35:57
Listen to the news
Fluicell's Cancer Drug Delivery Catheter Meets Ambusol's Functional Requirements
  • Fluicell delivered catheter design and performance data to Ambusol, meeting functional requirements for the current development phase.
  • The functional prototype took less than a year to develop from concept.
  • The technology targets cancer drug delivery directly to tumors with minimal systemic effects while simultaneously removing tumor and cell fragments.
  • Initial use targets glioblastoma treatment, advancing preparations for Ambusol’s planned Phase 2b trials in China in 2027.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fluicell AB published the original content used to generate this news brief on November 09, 2026, and is solely responsible for the information contained therein.